Here, we observed that MIF is increased in the MCI stage and strongly associated with sTREM1 and sTREM2 in all groups, supporting the hypothesis that MIF could be part of the neuroinflammatory response cascade already in early stages and might be useful as a disease monitoring biomarker along the AD continuum. This evidence concerns the gene MIF and Alzheimer disease.